BRIEF published on 07/30/2025 at 11:43, 10 months 10 days ago Medincell Releases 2024-25 Universal Registration Document Shareholders Governance Financial Report CSR Medincell
PRESS RELEASE published on 07/30/2025 at 11:38, 10 months 10 days ago Annual financial and audit reports / Terms of availability of the annual financial report Medincell announces availability of its 2024-25 Universal Registration Document, including financial and CSR reports. Innovative treatments developed aim to improve effectiveness of medicines Financial Reports Universal Registration Document CSR Innovative Treatments Medincell
BRIEF published on 05/07/2025 at 15:17, 1 year 1 month ago Medincell's Growth in Antipsychotic Treatments FDA Filing Medincell Olanzapine LAI UZEDY Antipsychotics
PRESS RELEASE published on 05/07/2025 at 15:12, 1 year 1 month ago Inside Information / Other news releases Medincell's UZEDY® sees strong sales growth in Q1 2025 with plans for Olanzapine LAI FDA submission in H2 2025. Teva's partner shares updates on key products Medincell FDA Submission Teva Pharmaceuticals Olanzapine LAI UZEDY
BRIEF published on 04/15/2025 at 19:53, 1 year 1 month ago Medincell increases its liquidity contract to support securities trading Liquidity Contract Rothschild Martin Maurel Actions EU Regulations Medincell
PRESS RELEASE published on 04/15/2025 at 19:48, 1 year 1 month ago Inside Information / Other news releases Medincell increases liquidity contract resources by 600,000 euros with Rothschild Martin Maurel to support higher trading volumes Liquidity Contract Rothschild Martin Maurel Amendment Medincell Trading Volumes
BRIEF published on 03/10/2025 at 11:54, 1 year 2 months ago Adage Capital exceeds 5% in MEDINCELL Euronext Paris Actions Threshold Crossing Medincell Adage Capital
BRIEF published on 02/25/2025 at 23:08, 1 year 3 months ago FDA Accepts Application for UZEDY's Use in Treating Bipolar I Disorder FDA Approval Medincell Teva Pharmaceuticals UZEDY Bipolar I Disorder
PRESS RELEASE published on 02/25/2025 at 23:03, 1 year 3 months ago Inside Information / Other news releases Teva and Medincell announce FDA acceptance of UZEDY(R) risperidone for bipolar I disorder treatment, expanding indications for this long-acting injectable antipsychotic FDA Medincell Teva UZEDY Bipolar I Disorder
BRIEF published on 02/19/2025 at 08:33, 1 year 3 months ago Medincell successfully completes its Global Offer of 42.9 million euros Fundraising International Investors Medincell Global Offer BEPO® Technology
Published on 06/10/2026 at 00:00, 4 hours 24 minutes ago Onco-Innovations Announces Initiation of API Process Development and Intermediate Scale-Up Program for its Proprietary PNKP Inhibitor Technology
Published on 06/09/2026 at 23:00, 5 hours 24 minutes ago NXT Energy Solutions Inc. Announces Results of Annual Meeting of Shareholders
Published on 06/09/2026 at 22:30, 5 hours 54 minutes ago Gamma Resources Announces Receipt of $604,500 from Warrant Exercises
Published on 06/09/2026 at 21:45, 6 hours 39 minutes ago Northfield Announces Change of Corporate Name to Juno International Corporation
Published on 06/09/2026 at 15:00, 13 hours 24 minutes ago Worksport Ltd. Reports Additional $50,000 CEO Insider Stock Acquisition, Reinforcing Confidence in Long-Term Value Creation
Published on 06/09/2026 at 22:55, 5 hours 29 minutes ago JACOBS STEPS-UP AS 'OFFICIAL SPONSOR OF STAYING AWAKE' AS SCHEDULE REVEALS SUMMER MATCH TIMES WILL PUSH EUROPEAN FOOTBALL FANS TO THE LIMIT
Published on 06/09/2026 at 22:35, 5 hours 49 minutes ago Eurobattery Minerals publishes Annual Report 2025
Published on 06/09/2026 at 19:32, 8 hours 52 minutes ago 2CRSi SA: 2CRSi announces a €110 million sale of Godì Blackwell Ultra servers in Germany
Published on 06/09/2026 at 19:10, 9 hours 14 minutes ago The 2026 Global Energy Prize shortlist released
Published on 06/09/2026 at 19:10, 9 hours 14 minutes ago THE SULTANATE OF OMAN CONSOLIDATES ITS POSITION AS A STABLE DESTINATION FOR GLOBAL CAPITAL
Published on 06/09/2026 at 19:30, 8 hours 54 minutes ago MONTHLY INFORMATION CONCERNING THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES
Published on 06/09/2026 at 18:14, 10 hours 10 minutes ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/05/2026
Published on 06/09/2026 at 15:17, 13 hours 7 minutes ago Statement of transactions in own shares from June 1, 2026 to June 5, 2026
Published on 06/09/2026 at 10:37, 17 hours 47 minutes ago Guillemot Corporation S.A. | Weekly report share buyback from June 1 to June 5 2026
Published on 06/09/2026 at 07:00, 21 hours 24 minutes ago New strategic Milestone for Biophytis: Official Establishment of Its Joint Venture in Asia
